Jeito Capital

Jeito Capital represents a forward-thinking investment firm dedicated to advancing revolutionary medical innovations while simultaneously generating positive societal outcomes. The fund distinguishes itself through a patient-centric investment philosophy that balances breakthrough scientific advancements with meaningful healthcare impact. Established as a next-generation venture capital entity, Jeito evaluates potential investments not only on financial merit but also on their capacity to address significant unmet medical needs and improve patient lives globally.

Entrepreneurs partnering with Jeito gain access to a comprehensive support ecosystem featuring a diverse, highly-qualified team of investment professionals with backgrounds spanning biotechnology, pharmaceuticals, medical devices, and healthcare services. This integrated multi-disciplinary approach provides portfolio companies with strategic guidance, industry connections, and operational expertise throughout their development journey. Jeito's hands-on investment style typically involves active board participation and close collaboration with management teams to navigate complex regulatory pathways and commercialization challenges.

Headquartered in Paris, Jeito Capital maintains a strategic transatlantic presence with operations across key European biotech hubs and the United States, positioning the firm to identify promising opportunities in major life sciences ecosystems. This geographic versatility enables Jeito to facilitate valuable cross-border collaborations and provide portfolio companies with access to diverse talent pools, regulatory expertise, and market entry strategies. The firm typically focuses on Series A through growth-stage investments in companies developing transformative therapeutics, innovative medical technologies, and digital health solutions.

Jeito has established a reputation for its long-term investment horizon, allowing portfolio companies sufficient runway to achieve significant clinical and commercial milestones without undue pressure for premature exits. The firm's investment thesis centers on backing scientifically differentiated assets addressing substantial markets with clear regulatory pathways. Beyond capital deployment, Jeito actively contributes to building a sustainable healthcare innovation ecosystem through knowledge sharing initiatives, industry partnerships, and talent development programs. The fund regularly shares insights through its communication channels, including announcements about new investments, portfolio achievements, and employment opportunities.